Taiwan Urged To Speed Up Clinical Trial Administrative Process
This article was originally published in PharmAsia News
Executive Summary
Taiwan’s institutional review board process is putting the brakes on the country’s competitive advantage, with some trial sites taking up to six months to grant approval for clinical trials.